Fanconi Anemia Pathway Activation by FOXM1 is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance

被引:17
|
作者
Roh, Yun-Gil [1 ]
Mun, Jeong-Yeon [1 ]
Kim, Seon-Kyu [2 ,3 ]
Park, Won Young [4 ]
Jeong, Mi-So [1 ]
Kim, Tae Nam [5 ]
Kim, Won-Tae [1 ]
Choi, Yung Hyun [6 ]
Chu, In-Sun [3 ,7 ]
Leem, Sun-Hee [1 ]
机构
[1] Dong A Univ, Dept Biol Sci, Busan 49315, South Korea
[2] Korea Res Inst Biosci & Biotechnol KRIBB, Personalized Genom Med Res Ctr, Daejeon 34141, South Korea
[3] Korea Univ Sci & Technol, KRIBB Sch Biosci, Dept Bioinformat, Daejeon 34113, South Korea
[4] Pusan Natl Univ Hosp, Med Res Inst, Dept Pathol, Busan 49241, South Korea
[5] Pusan Natl Univ Hosp, Med Res Inst, Dept Urol, Busan 49241, South Korea
[6] Dong Eui Univ, Coll Korean Med, Dept Biochem, Busan 47227, South Korea
[7] Korea Res Inst Biosci & Biotechnol KRIBB, Genome Editing Res Ctr, Daejeon 34141, South Korea
基金
新加坡国家研究基金会;
关键词
bladder cancer; FOXM1; FANCD2; Fanconi anemia pathway; DNA repair; cancer recurrence; TRANSCRIPTION FACTOR FOXM1; FORKHEAD BOX M1; DNA-DAMAGE; MASTER REGULATOR; EXPRESSION; PROGRESSION; APOPTOSIS; CELLS; EPIDEMIOLOGY; GUIDELINES;
D O I
10.3390/cancers12061417
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although the 5-year survival rate of patients diagnosed with nonmuscle invasive bladder cancer (NMIBC) has reached 85%, more than 50% of patients suffer from frequent recurrences. To identify molecular targets associated with recurrence of NMIBC, we analyzed gene expression data and found that FOXM1 and FANCD2 were involved in recurrence. Therefore, we investigated how these genes were involved in the mechanism of recurrence and confirmed their usefulness as biomarkers. Investigation have shown that FOXM1 directly regulated the transcription of FANCD2, which is the key gene of the Fanconi anemia (FA) pathway. Depletion of FOXM1 resulted in DNA repair defects in the FA pathway and in decreased resistance to chemotherapy. Thus, the FANCD2-associated FA pathway activated by FOXM1 is an important mechanism involved in chemotherapy-related recurrence. In conclusion, FOXM1 and FANCD2 can be used as prognostic factors that are associated with high risk of recurrence and with anticancer drug resistance properties in NMIBC patients.
引用
收藏
页码:1 / 20
页数:19
相关论文
共 50 条
  • [1] Drug resistance of bladder cancer cells through activation of ABCG2 by FOXM1
    Roh, Yun-Gil
    Mun, Mi-Hye
    Jeong, Mi-So
    Kim, Won-Tae
    Lee, Se-Ra
    Chung, Jin-Woong
    Kim, Seung Il
    Kim, Tae Nam
    Nam, Jong Kil
    Leem, Sun-Hee
    BMB REPORTS, 2018, 51 (02) : 98 - 103
  • [2] FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer
    Panneerselvam, Jayabal
    Park, Hwan Ki
    Zhang, Jun
    Dudimah, Fred Duafalia
    Zhang, Piyan
    Wang, Hong
    Fei, Peiwen
    CELL CYCLE, 2012, 11 (15) : 2947 - 2955
  • [3] Nucleophosmin1 associated with drug resistance and recurrence of bladder cancer
    Hu, Huihui
    Meng, Qian
    Lei, Ting
    Zhang, Man
    CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 15 (03) : 361 - 369
  • [4] FOXM1 promotes the growth and metastasis of colorectal cancer via activation of β-catenin signaling pathway
    Yang, Kankan
    Jiang, Bing
    Lui, Yecai
    Shu, Qingbing
    Zhai, Pan
    Zhi, Qiaoming
    Li, Qixin
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3779 - 3790
  • [5] FoxM1 Induced Paclitaxel Resistance via Activation of the FoxM1/PHB1/RAF-MEK-ERK Pathway and Enhancement of the ABCA2 Transporter
    Huang, Chao
    Zhang, Xin
    Jiang, Li
    Zhang, Limin
    Xiang, Ming
    Ren, Hongyu
    MOLECULAR THERAPY-ONCOLYTICS, 2019, 14 : 196 - 212
  • [6] Downregulation of FoxM1 inhibits cell growth and migration and invasion in bladder cancer cells
    Yang, Xinping
    Shi, Yuanyuan
    Yan, Jingzhe
    Fan, Haitao
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (02): : 629 - 638
  • [7] Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer
    Li, Meng
    Yang, Jingyu
    Zhou, Wenlong
    Ren, Yong
    Wang, Xiaoxuan
    Chen, Huiping
    Zhang, Jingyuan
    Chen, Junli
    Sun, Yuhong
    Cui, Lijuan
    Liu, Xing
    Wang, Lihui
    Wu, Chunfu
    BRITISH JOURNAL OF CANCER, 2017, 117 (07) : 974 - 983
  • [8] FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair
    Park, Yun-Yong
    Jung, Sung Yun
    Jennings, Nicholas B.
    Rodriguez-Aguayo, Cristian
    Peng, Guang
    Lee, Se-Ran
    Kim, Sang Bae
    Kim, Kyounghyun
    Leem, Sun-Hee
    Lin, Shiaw-Yih
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    Lee, Ju-Seog
    CARCINOGENESIS, 2012, 33 (10) : 1843 - 1853
  • [9] Activation of AKT/AP1/FoxM1 signaling confers sorafenib resistance to liver cancer cells
    Yan, Dongjing
    Yan, Xiaojing
    Dai, Xufang
    Chen, Lingxi
    Sun, Liangbo
    Li, Tao
    He, Fengtian
    Lian, Jiqin
    Cai, Wangwei
    ONCOLOGY REPORTS, 2019, 42 (02) : 785 - 796
  • [10] FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
    Kwok, Jimmy M. -M.
    Peck, Barrie
    Monteiro, Lara J.
    Schwenen, Helma D. C.
    Millour, Julie
    Coombes, R. Charles
    Myatt, Stephen S.
    Lam, Eric W. -F.
    MOLECULAR CANCER RESEARCH, 2010, 8 (01) : 24 - 34